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Dengue fever is considered one of the most threatening 
mosquito transmitted disease with 30-fold rise in 
incidence world-wide. Since the first ever known outbreak 
of dengue infection in Pakistan reported in 1994, there 
are increasing cases of variable intensity every year. In 
the current year, Pakistan is undergoing one of its worst-
ever dengue fever epidemics. The first case was reported 
on 8th July 2019 in Peshawar and since then it has spread 
like a fire all over the country apart from Islamabad, 
capital of Pakistan. From July to November 2019, a total 
of 47,120 confirmed patients having this disease and 175 
deaths are being notified1. 
 
The disease has hit urban areas of Pakistan, placing 
hospitals under severe strain. Authorities are conducting 
anti-mosquito spraying in urban areas to contain the 
spread of disease but due to limited resources, prolonged 
monsoon rains, lack of anticipation and timely measures 
by health authorities led to the outbreak.1 
 
Dengue fever is a viral infection caused by virus 
belonging to the Flaviviridae family. It is transmitted 
by bite of an infected female Aedes aegypti mosquitoes 
that feed during daytime (most cases at Fajr and Maghreb 
prayer time).2 This mosquito multiplies at places where 
there is plenty of clean stagnant water like ponds, 
underwater tank, jars, some empty container and old used 
tyres. Lack of knowledge regarding disease prevention, 
proper sanitation and regular garbage collection is also 
contributing to the spread of the mosquitoes in urban as 
well as rural areas.3 Risk of Dengue exists worldwide in 
tropical and subtropical areas like Central and South 
America, African countries and Asia especially in the sub -
continent, including Pakistan. Therefore, all people 
travelling to affected areas should be considered at high 
risk for disease acquisition during outbreaks.4  
 
The initial symptoms are mild body aches, fever with 
runny nose and itching go unnoticed and are usually not 
investigated. Those who develop illness usually develop 
symptoms during the first week after the bite of infectious 
mosquito. Early infection presents with flu-like symptoms 
(high-grade fever, redness and painful reddened eyes, 
severe myalgia, bone and joint pain, intractable 
headache), itching all over body along with a diffuse 
petechial or erythematous rash on skin.5 If untreated the 
illness occasionally may progress to dengue hemorrhagic 
fever (DHF ), in which patients present with pain in 
abdomen, loose stools, fits, pleural effusion, ascites and 
excessive tendency to bleed. Further complications may 
result in circulatory failure, shock and death (also known 
as Dengue Shock Syndrome). An important fact to 
recognize is that if a patient gets infected by same 
serotype of Dengue virus, it results in some immunity to 
future attacks of the virus. However, if the patient gets 
infected by another serotype, there is more chance to 
develop dengue hemorrhagic fever. Therefore, once 
dengue infection occurs, it is very important to prevent 
patients from further attacks in same as well as in 
subsequent seasons.6 
 
Laboratory confirmation of dengue fever involves isolation 
of virus, nucleic acid of virus, its antigen, antibody to 
dengue virus, or any combination of these diagnostic 
methods. In any suspected patient of dengue fever, 
organism can be isolated from serum, circulating RBCs or 
tissues for about 5 days by dengue NS1 antigen.7 After 
the acute phase of disease, serological tests like IgM and 
IgG antibodies in serum are considered as diagnostic 
tests for dengue infection.8 Ultrasound done timely is also 
a cost-effective and easily available diagnostic modality 
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for evaluating cases of suspected Dengue Hemorrhagic 
fever. This technique detects pleural effusion, ascites and 
thickening of gall bladder wall, all of which represent 
significant permeability of blood vessels.9 The utility of 
ultrasound in previous studies was limited because 
patients underwent only a single scan. Currently, serial 
ultrasound examination of thorax and abdomen of 
patients with dengue fever has been found very helpful  in 
detecting patients who are progressing to severe form of 
the disease.10 
 
So far, there is no proper therapy for mild or severe 
dengue fever, except supportive care along with methods 
for prevention. For severe aches, fever and pain 
Paracetamol can be used orally or in intravenous infusion. 
Patients are advised complete rest and plenty of fluids 
orally (I/V fluids if no oral intake due to vomiting). Patients 
with worsening of symptoms in the first 24 hours should 
be admitted to hospital immediately to monitor for disease 
progression and complications.11 
 
The only effective way of controlling this infection is 
protection from bite of infected mosquito, especially 
people travelling to endemic areas. Measures include 
protection of human beings from mosquito bites and 
taking measures for keeping control on mosquito 
population. Protective measures from dengue infection 
include use of anti-mosquito lotions, wearing long shirts 
and long pants which should be tucked into socks while 
going outside. The mosquito population can be reduced 
by getting rid of places where mosquitoes can breed e.g. 
used tyres, water cans, or household plant pots where 
rain water can collect, outdoor bird and pets' water 
dishes.12 Recently FDA has approved a vaccine, 
Dengvaxia, which is claimed to help in prevention of 
Dengue fever in children aged 9 to 16 years who are 
already infected by the Dengue virus.13 However, it is not 
available worldwide to prevent the disease in the general  
population, especially in endemic and under developed 
countries. 
 
Given the fact that dengue fever is a challenge to the 
existing health system and a burden on health services, i t 
could be tackled by applying simple, correct and timely 
treatment strategies. The management of dengue 
demands multi-pronged approach, involving relevant 
stakeholders beyond health sector and effectively 
implementing preventive strategies with cost-effective 
interventions. Dengue is becoming a global threat and it is 
a need of time to adopt worldwide strategy for its 
prevention and treatment by promoting integrated 
approach of vector management and sustainable control 
measures at all levels to reduce morbidity and mortality 
from dengue fever. 
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